JP2013513812A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013513812A5 JP2013513812A5 JP2012543890A JP2012543890A JP2013513812A5 JP 2013513812 A5 JP2013513812 A5 JP 2013513812A5 JP 2012543890 A JP2012543890 A JP 2012543890A JP 2012543890 A JP2012543890 A JP 2012543890A JP 2013513812 A5 JP2013513812 A5 JP 2013513812A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- sample
- cell sample
- isolated cell
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000523 sample Substances 0.000 claims 10
- 239000011230 binding agent Substances 0.000 claims 9
- 229920001184 polypeptide Polymers 0.000 claims 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 102000007066 Prostate-Specific Antigen Human genes 0.000 claims 5
- 108010072866 Prostate-Specific Antigen Proteins 0.000 claims 5
- 102000001307 androgen receptors Human genes 0.000 claims 5
- 108010080146 androgen receptors Proteins 0.000 claims 5
- 238000003556 assay Methods 0.000 claims 5
- 239000012472 biological sample Substances 0.000 claims 5
- 206010060862 Prostate cancer Diseases 0.000 claims 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 4
- 102100030960 DNA replication licensing factor MCM2 Human genes 0.000 claims 1
- 101000583807 Homo sapiens DNA replication licensing factor MCM2 Proteins 0.000 claims 1
- 101001018431 Homo sapiens DNA replication licensing factor MCM7 Proteins 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0921873.6 | 2009-12-15 | ||
| GBGB0921873.6A GB0921873D0 (en) | 2009-12-15 | 2009-12-15 | Assay |
| PCT/GB2010/002274 WO2011073619A1 (en) | 2009-12-15 | 2010-12-15 | Assay |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013513812A JP2013513812A (ja) | 2013-04-22 |
| JP2013513812A5 true JP2013513812A5 (enExample) | 2014-02-06 |
Family
ID=41667106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012543890A Pending JP2013513812A (ja) | 2009-12-15 | 2010-12-15 | アッセイ |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20130171662A1 (enExample) |
| EP (2) | EP2513651A1 (enExample) |
| JP (1) | JP2013513812A (enExample) |
| CN (1) | CN102782497A (enExample) |
| CA (1) | CA2807870A1 (enExample) |
| GB (1) | GB0921873D0 (enExample) |
| WO (1) | WO2011073619A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6854246B2 (ja) | 2015-06-08 | 2021-04-07 | アーケア ダイアグノスティクス リミテッド | 尿サンプルの分析方法 |
| EP4060344A1 (en) * | 2015-06-08 | 2022-09-21 | Arquer Diagnostics Limited | Methods and kits |
| GB201820868D0 (en) * | 2018-12-20 | 2019-02-06 | Arquer Diagnostics Ltd | Detection method |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6307030B1 (en) * | 1988-04-15 | 2001-10-23 | The University Of North Carolina At Chapel Hill | Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions |
| GB9704444D0 (en) * | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
| EP1025444B1 (en) * | 1997-10-21 | 2005-03-02 | Cancer Research Technology Limited | Determination of cellular growth abnormality |
| US6303323B1 (en) * | 1997-10-21 | 2001-10-16 | Cancer Research Campaign Technology Limited | Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies |
| US6355623B2 (en) * | 1998-09-24 | 2002-03-12 | Hopital-Sainte-Justine | Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage |
| US6566130B1 (en) * | 2000-01-28 | 2003-05-20 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Androgen-regulated gene expressed in prostate tissue |
| AU2002220265A1 (en) * | 2000-11-03 | 2002-05-15 | University Of Vermont And State Agricultural College | Compositions for inhibiting grb7 |
| WO2005020784A2 (en) * | 2003-05-23 | 2005-03-10 | Mount Sinai School Of Medicine Of New York University | Surrogate cell gene expression signatures for evaluating the physical state of a subject |
| US7666595B2 (en) * | 2005-02-25 | 2010-02-23 | The Brigham And Women's Hospital, Inc. | Biomarkers for predicting prostate cancer progression |
| US20060211059A1 (en) * | 2005-03-18 | 2006-09-21 | Taneja Samir S | Methods of improving screening, diagnosis and staging of prostate cancer using serum testosterone |
| CN101239181A (zh) * | 2007-02-08 | 2008-08-13 | 中国科学院上海生命科学研究院 | 一种和癌症有关的组蛋白去甲基化酶及其应用 |
| GB0720113D0 (en) * | 2007-10-15 | 2007-11-28 | Cambridge Cancer Diagnostics L | Diagnostic, prognostic and predictive testing for cancer |
| GB0800311D0 (en) | 2008-01-09 | 2008-02-20 | Cytosystems Ltd | Apparatus and method for filtering biological material |
| GB0811567D0 (en) * | 2008-06-24 | 2008-07-30 | Cytosystems Ltd | Assay |
-
2009
- 2009-12-15 GB GBGB0921873.6A patent/GB0921873D0/en not_active Ceased
-
2010
- 2010-12-15 EP EP10801208A patent/EP2513651A1/en not_active Ceased
- 2010-12-15 JP JP2012543890A patent/JP2013513812A/ja active Pending
- 2010-12-15 US US13/512,823 patent/US20130171662A1/en not_active Abandoned
- 2010-12-15 WO PCT/GB2010/002274 patent/WO2011073619A1/en not_active Ceased
- 2010-12-15 EP EP15185015.3A patent/EP2977762A3/en not_active Withdrawn
- 2010-12-15 CA CA2807870A patent/CA2807870A1/en not_active Abandoned
- 2010-12-15 CN CN2010800568880A patent/CN102782497A/zh active Pending
-
2014
- 2014-09-17 US US14/489,207 patent/US10267801B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011524537A5 (enExample) | ||
| US10705089B2 (en) | Methods and kits for the diagnosis of cancer | |
| JP2014508298A5 (enExample) | ||
| BR112013010213A2 (pt) | anticorpos que unem ligantes solúveis de receptores de célula t | |
| WO2016094761A3 (en) | Test apparatus and methods for st2 cardiac biomarker | |
| JP2008530582A5 (enExample) | ||
| NZ599105A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| JP2015533788A5 (enExample) | ||
| BR112012019542A2 (pt) | "método para avaliar o estado renal em um indivíduo, medição de um ou mais biomarcadores, e, kit" | |
| JP2013521763A5 (enExample) | ||
| JP2006502416A5 (enExample) | ||
| WO2010002911A3 (en) | Methods and materials for monitoring myeloma using quantitative mass spetrometry | |
| WO2012017082A3 (de) | Anti-la antikörper und ihre anwendung zum immunotargeting | |
| JP2015505370A5 (enExample) | ||
| MY172290A (en) | Immunochromatography devices, methods, and, kits | |
| EA201291314A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| JP2011102805A5 (enExample) | ||
| JP2012501318A5 (enExample) | ||
| ATE474857T1 (de) | Antikörper gegen ein epitop auf agr2, assays und hybridome | |
| WO2009121024A3 (en) | Methods for detecting antibodies | |
| JP2013174612A5 (enExample) | ||
| WO2013028807A3 (en) | Renal cell carcinoma biomarkers and uses thereof | |
| JP2016536568A5 (enExample) | ||
| RU2015104737A (ru) | Способ обнаружения мультиспецифического связывающего агента | |
| EA200702361A1 (ru) | АНТИТЕЛА ПРОТИВ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ |